| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $162.1M | — | +106.9% |
| Cost of Revenue | $9.4M | — | +80.3% |
| R&D Expense | $22.4M | — | +55.1% |
| SG&A Expense | $136.4M | — | +60.5% |
| Operating Income | -$6.1M | — | +76.7% |
| Interest Expense | $2.1M | — | -3.8% |
| Income Tax | $2.4M | — | — |
| Net Income | -$7.0M | — | +72.3% |
| EPS (Basic) | -$0.16 | — | +75.0% |
| EPS (Diluted) | -$0.16 | — | +75.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $102.2M | -44.4% | -41.9% |
| Short-term Investments | $286.5M | +22.6% | +23.4% |
| Accounts Receivable | $100.3M | +18.0% | +60.7% |
| Inventory | $4.6M | +4.6% | +69.0% |
| Current Assets | $537.2M | +2.8% | +11.7% |
| Total Assets | $581.1M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$24.7M | — | -19.4% |
| Capital Expenditures | $5.8M | — | +886.1% |
| Investing Cash Flow | -$58.6M | — | -67.6% |
| Financing Cash Flow | $1.2M | — | -99.1% |
| Free Cash Flow | -$30.5M | — | -43.4% |
| +16.1% |
| Current Liabilities | $143.5M | +5.8% | +66.3% |
| Long-term Debt | $72.6M | +0.2% | +0.9% |
| Total Liabilities | $232.2M | +6.1% | +46.7% |
| Stockholders' Equity | $349.0M | +1.6% | +1.9% |